| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | -0.0088 | 0.8 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | 0.0072 | 0.8 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | 0.0084 | 0.8 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | -0.0066 | 0.8 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0077 | 0.8 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | -0.0069 | 0.8 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.0078 | 0.8 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | -0.0078 | 0.8 |